Related content

Analysis of somatic mutations in braf, CDKN2A/p16 and PI3KCA in patients with medullary thyroid carcinoma

By                    

Molecular Medicine Reports, Vol. 13, Iss. 2, 2016-01 ,pp. : 1653-1660

Spandidos Publications

Access to resources Recommend Favorite

Infrequent mutations and no methylation of CDKN2A (p16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan

By Lin Y.-W.   Chen C.-H.   Huang G.-T.   Lee P.-H.   Wang J.-T.   Chen D.-S.   Lu F.-J.   Sheu J.-C.  

European Journal of Cancer, Vol. 34, Iss. 11, 1998-10 ,pp. : 1789-1795

Elsevier

Access to resources Recommend Favorite

Frequent Deletion and Methylation in SH3GL2 and CDKN2A Loci are Associated with Early- and Late-onset Breast Carcinoma

By Sinha Satyabrata  

Annals of Surgical Oncology, Vol. 15, Iss. 4, 2008-04 ,pp. : 1070-1080

Springer Publishing Company

Access to resources Recommend Favorite

Somatic Mutations

By  

International Journal of Cancer Research and Prevention, Vol. , Iss. , 2017-01 ,pp. : 107-109

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families

By Slater Emily   Langer Peter   Fendrich Volker   Habbe Nils   Chaloupka Brunhilde   Matthäi Elvira   Sina Mercedes   Hahn Stephan   Bartsch Detlef  

Familial Cancer, Vol. 9, Iss. 3, 2010-09 ,pp. : 335-343

Springer Publishing Company

Access to resources Recommend Favorite